Athenex Inc.

3.39+0.2100+6.60%Vol 2.29M1Y Perf -73.23%
Sep 15th, 2021 16:00 DELAYED
BID3.38 ASK3.39
Open3.37 Previous Close3.18
Pre-Market- After-Market-
 - -%  - -
Target Price
9.25 
Analyst Rating
Strong Buy 1.20
Potential %
172.86 
Finscreener Ranking
★★★★+     55.40
Insiders Trans % 3/6/12 mo.
-/100/76 
Value Ranking
★+     43.21
Insiders Value % 3/6/12 mo.
-/100/-77 
Growth Ranking
★★     44.34
Insiders Shares Cnt. % 3/6/12 mo.
-/100/-85 
Income Ranking
 —    -
Price Range Ratio 52W %
2.27 
Earnings Rating
Neutral
Market Cap370.55M 
Earnings Date
4th Nov 2021
Alpha-0.02 Standard Deviation0.19
Beta0.59 

Today's Price Range

3.293.52

52W Range

3.1215.00

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-2.87%
1 Month
3.99%
3 Months
-29.23%
6 Months
-33.53%
1 Year
-73.23%
3 Years
-79.47%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
ATNX3.390.21006.60
AAPL149.030.91000.61
GOOG2 904.1236.00001.26
MSFT304.825.03001.68
XOM56.421.84003.37
WFC46.640.59001.28
JNJ165.420.62000.38
FB373.92-2.6100-0.69
GE102.161.78001.77
JPM158.161.09000.69
Financial StrengthValueIndustryS&P 500US Markets
2.40
3.40
0.45
0.86
-7.50
Leverage Ratio 2.10
ProfitabilityValueIndustryS&P 500US Markets
34.40
-115.70
-111.70
-228.30
-79.98
RevenueValueIndustryS&P 500US Markets
120.23M
1.10
16.42
43.75
Earnings HistoryEstimateReportedSurprise %
Q02 2021-0.41-0.3319.51
Q01 2021-0.37-0.2727.03
Q04 2020-0.42-0.53-26.19
Q03 2020-0.46-0.444.35
Q02 2020-0.31-0.41-32.26
Q01 2020-0.21-0.24-14.29
Q04 2019-0.50-0.2844.00
Q03 2019-0.46-0.452.17
Earnings Per EndEstimateRevision %Trend
9/2021 QR-0.32-3.23Negative
12/2021 QR0.03400.00Positive
12/2021 FY-1.226.15Positive
12/2022 FY-0.875.43Positive
Next Report Date4th Nov 2021
Estimated EPS Next Report-0.32
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume2.29M
Shares Outstanding109.31M
Shares Float77.82M
Trades Count12.85K
Dollar Volume21.94M
Avg. Volume3.33M
Avg. Weekly Volume1.38M
Avg. Monthly Volume1.13M
Avg. Quarterly Volume1.25M

Athenex Inc. (NASDAQ: ATNX) stock closed at 3.39 per share at the end of the most recent trading day (a 6.6% change compared to the prior day closing price) with a volume of 2.30M shares and market capitalization of 370.55M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 581 people. Athenex Inc. CEO is Johnson Y.N. Lau.

The one-year performance of Athenex Inc. stock is -73.23%, while year-to-date (YTD) performance is -69.35%. ATNX stock has a five-year performance of %. Its 52-week range is between 3.12 and 15, which gives ATNX stock a 52-week price range ratio of 2.27%

Athenex Inc. currently has a PE ratio of -2.10, a price-to-book (PB) ratio of 1.97, a price-to-sale (PS) ratio of 3.05, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -40.26%, a ROC of -43.67% and a ROE of -87.67%. The company’s profit margin is -79.98%, its EBITDA margin is -111.70%, and its revenue ttm is $120.23 Million , which makes it $1.10 revenue per share.

Of the last four earnings reports from Athenex Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.32 for the next earnings report. Athenex Inc.’s next earnings report date is 04th Nov 2021.

The consensus rating of Wall Street analysts for Athenex Inc. is Strong Buy (1.2), with a target price of $9.25, which is +172.86% compared to the current price. The earnings rating for Athenex Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Athenex Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Athenex Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 32.55, ATR14 : 0.21, CCI20 : -42.31, Chaikin Money Flow : -0.06, MACD : -0.09, Money Flow Index : 39.70, ROC : -6.87, RSI : 44.66, STOCH (14,3) : 30.67, STOCH RSI : 0.75, UO : 42.16, Williams %R : -69.33), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Athenex Inc. in the last 12-months were: A. Kim Campbell (Buy at a value of $43 518), Jinn Wu (Option Excercise at a value of $227 500), Jinn Wu (Sold 98 000 shares of value $465 500 ), John M. Vierling (Buy at a value of $7 988), Johnson Y.N. Lau (Buy at a value of $212 310), Johnson Y.N. Lau (Option Excercise at a value of $364 000), Kim Campbell (Buy at a value of $43 518), Rudolf Kwan (Option Excercise at a value of $109 200), William Zuo (Sold 419 931 shares of value $1 898 088 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (80.00 %)
4 (80.00 %)
4 (80.00 %)
Moderate Buy
1 (20.00 %)
1 (20.00 %)
1 (20.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.20
Strong Buy
1.20
Strong Buy
1.20

Athenex Inc.

Athenex Inc is a global biopharmaceutical company. It is dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer. The company's operating segment includes the Oncology Innovation Platform; Global Supply Chain Platform and Commercial Platform. It generates maximum revenue from the Commercial Platform segment. Commercial Platform segment includes APD, which focuses on the manufacturing, distribution, and sales of specialty pharmaceuticals. Geographically, it derives a majority of revenue from the United States and also has a presence in Spain; Austria; India; China; the United Kingdom and Other foreign countries.

CEO: Johnson Y.N. Lau

Telephone: +1 716 427-2950

Address: 1001 Main Street, Buffalo 14203, NY, US

Number of employees: 581

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

100%0%

Bearish Bullish

54%46%

Bearish Bullish

51%49%

TipRanks News for ATNX

Thu, 05 Aug 2021 17:55 GMT Athenex (ATNX) Gets a Hold Rating from Needham

- TipRanks. All rights reserved.

News

Stocktwits